• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    2.05 Up 0.05(2.50%) 4:05PM EDT
    Add to Portfolio
    Prev Close:2.00
    Open:2.00
    Bid:2.02 x 5300
    Ask:2.03 x 7700
    1y Target Est:2.70
    Beta:-0.343193
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:1.99 - 2.05
    52wk Range:0.97 - 2.05
    Volume:1,171,853
    Avg Vol (3m):582,342
    Market Cap:308.94M
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBUp 2.50%308.94M
    LLYDown 1.57%85.06B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):31.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.20
    Quarterly EPS Est (Sep-15) :-0.04
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a precision medicine company, focuses on the development and commercialization of precision diagnostics, therapeutics, and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback